Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Senti

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Immunology|November 15, 2005
Heat denaturation, a simple method to improve the immunotherapeutic potential of allergensPål Johansen, Gabriela Senti, Julia Maria Martínez Gómez, et al.
Current Treatment Options in Allergy|February 28, 2015
Is The Allergen Really Needed in Allergy Immunotherapy?Thomas M Kündig, Ludger Klimek, Philipp Schendzielorz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2007
Evaluation of visual analog scales for the assessment of symptom severity in allergic rhinoconjunctivitisGabriela Senti, Bettina Mareike Prinz Vavricka, Nicole Graf, et al.
International Archives of Allergy and Immunology|April 3, 2009
Intralymphatic injections as a new administration route for allergen-specific immunotherapyJulia M Martínez-Gómez, Pål Johansen, Iris Erdmann, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2011
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation studyGabriela Senti, Seraina von Moos, Fabian Tay, et al.
Vaccine|October 18, 2005
Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responsesLucie Heinzerling, Veronique Basch, Kevin Maloy, et al.
International Archives of Allergy and Immunology|September 1, 2006
A cutaneous allergen neutralisation test that correlates with the duration of venom immunotherapyGabriela Senti, Pål Johansen, Ruben Oliver, et al.
Frontiers in Allergy|April 7, 2022
Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in HumansAlexandra Chabot, Gabriela Senti, Iris Erdmann, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapyGabriela Senti, Nicole Graf, Susanne Haug, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-upYasmin K Adlany, Lara Šošić, Gabriela Senti, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Immunology|November 15, 2005
Heat denaturation, a simple method to improve the immunotherapeutic potential of allergensPål Johansen, Gabriela Senti, Julia Maria Martínez Gómez, et al.
Current Treatment Options in Allergy|February 28, 2015
Is The Allergen Really Needed in Allergy Immunotherapy?Thomas M Kündig, Ludger Klimek, Philipp Schendzielorz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2007
Evaluation of visual analog scales for the assessment of symptom severity in allergic rhinoconjunctivitisGabriela Senti, Bettina Mareike Prinz Vavricka, Nicole Graf, et al.
International Archives of Allergy and Immunology|April 3, 2009
Intralymphatic injections as a new administration route for allergen-specific immunotherapyJulia M Martínez-Gómez, Pål Johansen, Iris Erdmann, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2011
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation studyGabriela Senti, Seraina von Moos, Fabian Tay, et al.
Vaccine|October 18, 2005
Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responsesLucie Heinzerling, Veronique Basch, Kevin Maloy, et al.
International Archives of Allergy and Immunology|September 1, 2006
A cutaneous allergen neutralisation test that correlates with the duration of venom immunotherapyGabriela Senti, Pål Johansen, Ruben Oliver, et al.
Frontiers in Allergy|April 7, 2022
Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in HumansAlexandra Chabot, Gabriela Senti, Iris Erdmann, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapyGabriela Senti, Nicole Graf, Susanne Haug, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-upYasmin K Adlany, Lara Šošić, Gabriela Senti, et al.
Pageof 5